The nuclear envelope environment and its cancer connections

Nature Reviews Cancer

Volumn 12, Issue 3, 2012, Pages 196-209

  Chow, Kin Hoe ^a   Factor, Rachel E ^a   Ullman, Katharine S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; EMERIN; HISTONE DEACETYLASE INHIBITOR; LAMIN; LAMIN B; LAMININ BINDING PROTEIN; MEMBRANE PROTEIN; NUCLEOPORIN; NUCLEOPORIN 133; NUCLEOPORIN 214; NUCLEOPORIN 98; NUP153 PROTEIN; ONCOPROTEIN; PROTEIN FARNESYLTRANSFERASE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RAD50 PROTEIN; RAD51 PROTEIN; RNA POLYMERASE II; SMAD PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SUMO PROTEIN; SUN DOMAIN CONTAINING PROTEIN 1; UBIQUITIN; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANEUPLOIDY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CARCINOGENESIS; CELL ADHESION; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL DIVISION; CELL MIGRATION; CELL MOTILITY; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CELL STRUCTURE; CENTROSOME; DNA REPAIR; DRUG INHIBITION; GENE EXPRESSION; GENE OVEREXPRESSION; GENOMIC INSTABILITY; HUMAN; MITOSIS; MOLECULAR BIOLOGY; NEOPLASM; NONHUMAN; NUCLEAR PORE COMPLEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIVISION; HUMANS; NEOPLASMS; NUCLEAR ENVELOPE; SIGNAL TRANSDUCTION;

EID: 84857655359     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3219     Document Type: Review

References (189)

1. Dey, P. Cancer nucleus: morphology and beyond. Diagn. Cytopathol. 38, 382-390 (2010).
2. True, L. D. & Jordan, C. D. The cancer nuclear microenvironment: interface between light microscopic cytology and molecular phenotype. J. Cell. Biochem. 104, 1994-2003 (2008).
3. Wilson, K. L. & Berk, J. M. The nuclear envelope at a glance. J. Cell. Sci. 123, 1973-1978 (2010).
4. Wente, S. R. & Rout, M. P. The nuclear pore complex and nuclear transport. Cold Spring Harb. Perspect. Biol. 2, a000562 (2010).
5. Chatel, G. & Fahrenkrog, B. Nucleoporins: Leaving the nuclear pore complex for a successful mitosis. Cell Signal 13 Jun. 2011 (doi:10.1016/j. cellsig.2011.05.023).
6. Dauer, W. T. & Worman, H. J. The nuclear envelope as a signaling node in development and disease. Dev. Cell 17, 626-638 (2009).
7. Friedl, P., Wolf, K. & Lammerding, J. Nuclear mechanics during cell migration. Curr. Opin. Cell Biol. 23, 55-64 (2011).
8. Olins, A. L. et al. The LINC-less granulocyte nucleus. Eur. J. Cell Biol. 88, 203-214 (2009).
9. Méjat, A. & Misteli, T. LINC complexes in health and disease. Nucleus 1, 40-52 (2010).
10. Starr, D. A. & Fridolfsson, H. N. Interactions between nuclei and the cytoskeleton are mediated by SUN-KASH nuclear-envelope bridges. Annu. Rev. Cell Dev. Biol. 26, 421-444 (2010).
11. Khatau, S. B. et al. A perinuclear actin cap regulates nuclear shape. Proc. Natl Acad. Sci. USA 106, 19017-19022 (2009).
12. Luxton, G. W. G., Gomes, E. R., Folker, E. S., Vintinner, E. & Gundersen, G. G. Linear arrays of nuclear envelope proteins harness retrograde actin flow for nuclear movement. Science 329, 956-959 (2010).
13. Capo-chichi, C. D., Cai, K. Q., Testa, J. R., Godwin, A. K. & Xu, X.-X. Loss of GATA6 leads to nuclear deformation and aneuploidy in ovarian cancer. Mol. Cell. Biol. 29, 4766-4777 (2009).
14. Butcher, D. T., Alliston, T. & Weaver, V. M. A tense situation: forcing tumour progression. Nature Rev. Cancer 9, 108-122 (2009).
15. Lombardi, M. L. et al. The interaction between nesprins and sun proteins at the nuclear envelope is critical for force transmission between the nucleus and cytoskeleton. J. Biol. Chem. 286, 26743-26753 (2011).
16. Willis, N. D. et al. Lamin A/C is a risk biomarker in colorectal cancer. PLoS ONE 3, e2988 (2008). The authors found that lamin A expression in colorectal cancer tissue is predictive of poor prognosis, and uncovered a role of lamin A in enhancing cell motility and invasiveness.
17. Zhou, L. & Panté, N. The nucleoporin Nup153 maintains nuclear envelope architecture and is required for cell migration in tumor cells. FEBS Lett. 584, 3013-3020 (2010).
18. Joseph, J. & Dasso, M. The nucleoporin Nup358 associates with and regulates interphase microtubules. FEBS Lett. 582, 190-196 (2008).
19. Murawala, P., Tripathi, M. M., Vyas, P., Salunke, A. & Joseph, J. Nup358 interacts with APC and plays a role in cell polarization. J. Cell. Sci. 122, 3113-3122 (2009).
20. Collin, L., Schlessinger, K. & Hall, A. APC nuclear membrane association and microtubule polarity. Biol. Cell 100, 243-252 (2008).
21. Hubert, T., Vandekerckhove, J. & Gettemans, J. Exo70-mediated recruitment of nucleoporin Nup62 at the leading edge of migrating cells is required for cell migration. Traffic 10, 1257-1271 (2009).
22. Gloerich, M. et al. The nucleoporin Ran BP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. J. Cell Biol. 193, 1009-1020 (2011).
23. Liu, C. et al. The interaction of Epac1 and Ran promotes Rap1 activation at the nuclear envelope. Mol. Cell. Biol. 30, 3956-3969 (2010).
24. Susaki, E. & Nakayama, K. I. Multiple mechanisms for p27 (Kip1) translocation and degradation. Cell Cycle 6, 3015-3020 (2007).
25. Gavet, O. & Pines, J. Activation of cyclin B1-Cdk1 synchronizes events in the nucleus and the cytoplasm at mitosis. J. Cell Biol. 189, 247-259 (2010).
26. Chakraborty, P. et al. Nucleoporin levels regulate cell cycle progression and phase-specific gene expression. Dev. Cell 15, 657-667 (2008).
27. Palancade, B. & Doye, V. Sumoylating and desumoylating enzymes at nuclear pores: underpinning their unexpected duties? Trends Cell Biol. 18, 174-183 (2008).
28. Xu, Y. et al. SUMO-specific protease 1 regulates the in vitro and in vivo growth of colon cancer cells with the upregulated expression of CDK inhibitors. Cancer Lett. 309, 78-84 (2011).
29. Dorner, D., Gotzmann, J. & Foisner, R. Nucleoplasmic lamins and their interaction partners, LAP2α, Rb, and BAF, in transcriptional regulation. FEBS J. 274, 1362-1373 (2007).
30. Burke, B. & Ellenberg, J. Remodelling the walls of the nucleus. Nature Rev. Mol. Cell Biol. 3, 487-497 (2002).
31. Mackay, D. R., Makise, M. & Ullman, K. S. Defects in nuclear pore assembly lead to activation of an Aurora B-mediated abscission checkpoint. J. Cell Biol. 191, 923-931 (2010).
32. Dar, A. A., Goff, L. W., Majid, S., Berlin, J. & El-Rifai, W. Aurora kinase inhibitors - rising stars in cancer therapeutics? Mol. Cancer Ther. 9, 268-278 (2010).
33. Verstraeten, V. L. R. M. et al. Protein farnesylation inhibitors cause donut-shaped cell nuclei attributable to a centrosome separation defect. Proc. Natl Acad. Sci. USA 108, 4997-5002 (2011). This study reports how a striking nuclear phenotype that results from inhibition of FNT is tied to the disruption of centrosome separation and a role for lamin B1, pointing to a novel mechanism that contributes to downstream consequences of this class of chemotherapy.
34. Sebti, S. M. & Der, C. J. Opinion: Searching for the elusive targets of farnesyltransferase inhibitors. Nature Rev. Cancer 3, 945-951 (2003).
35. Bolhy, S. et al. A Nup133-dependent NPC-anchored network tethers centrosomes to the nuclear envelope in prophase. J. Cell Biol. 192, 855-871 (2011).
36. Splinter, D. et al. Bicaudal D2, dynein, and kinesin-1 associate with nuclear pore complexes and regulate centrosome and nuclear positioning during mitotic entry. PLoS Biol. 8, e1000350 (2010).
37. Silkworth, W. T., Nardi, I. K., Paul, R., Mogilner, A. & Cimini, D. Timing of centrosome separation is important for accurate chromosome segregation. Mol. Biol. Cell 30 Nov. 2011 (doi:10.1091/mbc. E11-02-0095). The authors observe that when centrosomes do not fully separate prior to nuclear envelope breakdown, there is a greater likelihood of defective kinetochore attachment to mitotic spindles and aberrant chromosome segregation.
38. Dawlaty, M. M. et al. Resolution of sister centromeres requires Ran BP2-mediated SUMOylation of topoisomerase IIα. Cell 133, 103-115 (2008). This study reports a tumour-suppressive function of NUP358 that is attributed to the regulation of topoisomerase IIα sumoylation.
39. Zhang, X.-D. et al. SUMO-2/3 modification and binding regulate the association of CENP-E with kinetochores and progression through mitosis. Mol. Cell 29, 729-741 (2008).
40. Klein, U. R., Haindl, M., Nigg, E. A. & Muller, S. RanBP2 and SENP3 function in a mitotic SUMO2/3 conjugation-deconjugation cycle on Borealin. Mol. Biol. Cell 20, 410-418 (2009).
41. Ban, R., Nishida, T. & Urano, T. Mitotic kinase Aurora-B is regulated by SUMO-2/3 conjugation/deconjugation during mitosis. Genes Cells 16, 652-669 (2011).
42. Hang, J. & Dasso, M. Association of the human SUMO-1 protease SENP2 with the nuclear pore. J. Biol. Chem. 277, 19961-19966 (2002).
43. Ryu, H., Furuta, M., Kirkpatrick, D., Gygi, S. P. & Azuma, Y. PIASy-dependent SUMOylation regulates DNA topoisomerase IIα activity. J. Cell Biol. 191, 783-794 (2010).
44. Gardner, L., Malik, R., Shamizu, Y., Mullins, N. & Elshamy, W. M. Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation leading to aneuploidy in human mammary epithelial cells. Breast Cancer Res. 13, R53 (2011).
45. Jacques, C. et al. Two-step differential expression analysis reveals a new set of genes involved in thyroid oncocytic tumors. J. Clin. Endocrinol. Metab. 90, 2314-2320 (2005).
46. Cheng, J., Bawa, T., Lee, P., Gong, L. & Yeh, E. T. H. Role of desumoylation in the development of prostate cancer. Neoplasia 8, 667-676 (2006).
47. Gómez-Baldó, L. et al. TACC3-TSC2 maintains nuclear envelope structure and controls cell division. Cell Cycle 9, 1143-1155 (2010).
48. Lee, S. H., Sterling, H., Burlingame, A. & McCormick, F. Tpr directly binds to Mad1 and Mad2 and is important for the Mad1-Mad2-mediated mitotic spindle checkpoint. Genes Dev. 22, 2926-2931 (2008).
49. Schvartzman, J.-M., Sotillo, R. & Benezra, R. Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nature Rev. Cancer 10, 102-115 (2010).
50. Cross, M. K. & Powers, M. A. Nup98 regulates bipolar spindle assembly through association with microtubules and opposition of MCAK. Mol. Biol. Cell 22, 661-672 (2011).
51. Xu, S. & Powers, M. A. Nuclear pore proteins and cancer. Semin. Cell Dev. Biol. 20, 620-630 (2009).
52. Jeganathan, K. B., Baker, D. J. & van Deursen, J. M. Securin associates with APCCdh1 in prometaphase but its destruction is delayed by Rae1 and Nup98 until the metaphase/anaphase transition. Cell Cycle 5, 366-370 (2006).
53. Jeganathan, K. B., Malureanu, L. & van Deursen, J. M. The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation. Nature 438, 1036-1039 (2005).
54. Tsai, M.-Y. et al. A mitotic lamin B matrix induced by RanGTP required for spindle assembly. Science 311, 1887-1893 (2006).
55. Civelekoglu-Scholey, G., Tao, L., Brust-Mascher, I., Wollman, R. & Scholey, J. M. Prometaphase spindle maintenance by an antagonistic motor-dependent force balance made robust by a disassembling lamin-B envelope. J. Cell Biol. 188, 49-68 (2010).
56. Korfali, N. et al. A flow cytometry-based screen of nuclear envelope transmembrane proteins identifies NET4/Tmem53 as involved in stress-dependent cell cycle withdrawal. PLoS ONE 6, e18762 (2011). The results in this paper highlight the importance of the nuclear envelope as a source for cell cycle regulatory proteins, many of which have not yet been characterized.
57. Draviam, V. M. et al. A functional genomic screen identifies a role for TAO1 kinase in spindlecheckpoint signalling. Nat. Cell Biol. 9, 556-564 (2007).
58. Ruault, M., Dubarry, M. & Taddei, A. Re-positioning genes to the nuclear envelope in mammalian cells: impact on transcription. Trends Genet. 24, 574-581 (2008).
59. Batrakou, D. G., Kerr, A. R. W. & Schirmer, E. C. Comparative proteomic analyses of the nuclear envelope and pore complex suggests a wide range of heretofore unexpected functions. J. Proteomics 72, 56-70 (2009).
60. Andrés, V. & González, J. M. Role of A-type lamins in signaling, transcription, and chromatin organization. J. Cell Biol. 187, 945-957 (2009).
61. Malhas, A., Saunders, N. J. & Vaux, D. J. The nuclear envelope can control gene expression and cell cycle progression via miRNA regulation. Cell Cycle 9, 531-539 (2010). This study underscores the effect of the nuclear lamina on regulating genes with key roles in cancer, including miRNAs.
62. Bandrés, E. et al. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer 5, 29 (2006).
63. Valastyan, S., Chang, A., Benaich, N., Reinhardt, F. & Weinberg, R. A. Activation of miR-31 function in already-established metastases elicits metastatic regression. Genes Dev. 25, 646-659 (2011).
64. Valastyan, S. et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137, 1032-1046 (2009).
65. Xu, L., Kang, Y., Cöl, S. & Massagué, J. Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFβ signaling complexes in the cytoplasm and nucleus. Mol. Cell 10, 271-282 (2002).
66. Xylourgidis, N., Roth, P., Sabri, N., Tsarouhas, V. & Samakovlis, C. The nucleoporin Nup214 sequesters CRM1 at the nuclear rim and modulates NFkappaB activation in Drosophila. J. Cell. Sci. 119, 4409-4419 (2006).
67. Takahashi, N. et al. Tumor marker nucleoporin 88 kDa regulates nucleocytoplasmic transport of NF-kappaB. Biochem. Biophys. Res. Commun. 374, 424-430 (2008).
68. Capelson, M. et al. Chromatin-bound nuclear pore components regulate gene expression in higher eukaryotes. Cell 140, 372-383 (2010).
69. Vaquerizas, J. M. et al. Nuclear pore proteins nup153 and megator define transcriptionally active regions in the Drosophila genome. PLoS Genet. 6, e1000846 (2010).
70. Kalverda, B., Pickersgill, H., Shloma, V. V. & Fornerod, M. Nucleoporins directly stimulate expression of developmental and cell-cycle genes inside the nucleoplasm. Cell 140, 360-371 (2010).
71. Brown, C. R., Kennedy, C. J., Delmar, V. A., Forbes, D. J. & Silver, P. A. Global histone acetylation induces functional genomic reorganization at mammalian nuclear pore complexes. Genes Dev. 22, 627-639 (2008).
72. Kehat, I., Accornero, F., Aronow, B. J. & Molkentin, J. D. Modulation of chromatin position and gene expression by HDAC4 interaction with nucleoporins. J. Cell Biol. 193, 21-29 (2011).
73. Dickinson, M., Johnstone, R. W. & Prince, H. M. Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect. Invest. New Drugs 28 (Suppl. 1), 3-20 (2010).
74. Arib, G. & Akhtar, A. Multiple facets of nuclear periphery in gene expression control. Curr. Opin. Cell Biol. 23, 346-353 (2011).
75. Kind, J. & van Steensel, B. Genome-nuclear lamina interactions and gene regulation. Curr. Opin. Cell Biol. 22, 320-325 (2010).
76. Shimi, T. et al. The A-and B-type nuclear lamin networks: microdomains involved in chromatin organization and transcription. Genes Dev. 22, 3409-3421 (2008).
77. Mewborn, S. K. et al. Altered chromosomal positioning, compaction, and gene expression with a lamin A/C gene mutation. PLoS ONE 5, e14342 (2010).
78. Ottaviani, A., Schluth-Bolard, C., Gilson, E. & Magdinier, F. D4Z4 as a prototype of CTCF and laminsdependent insulator in human cells. Nucleus 1, 30-36 (2010).
79. Kalverda, B. & Fornerod, M. Characterization of genome-nucleoporin interactions in Drosophila links chromatin insulators to the nuclear pore complex. Cell Cycle 9, 4812-4817 (2010).
80. Helfand, B. T. et al. Chromosomal regions associated with prostate cancer risk localize to lamin B deficient microdomains and exhibit reduced gene transcription. J. Pathol. 25 Oct. 2011 (doi:10.1002/path.3033). The authors track the distribution of lamin proteins in prostate cancer and find that the frequency of nuclear blebs deficient in B-type lamins corresponds to the severity of Gleason grade.
81. Prokocimer, M. et al. Nuclear lamins: key regulators of nuclear structure and activities. J. Cell. Mol. Med. 13, 1059-1085 (2009).
82. Maraldi, N. M., Capanni, C., Cenni, V., Fini, M. & Lattanzi, G. Laminopathies and lamin-associated signaling pathways. J. Cell. Biochem. 112, 979-992 (2011).
83. Neumann, S. et al. Nesprin-2 interacts with α-catenin and regulates Wnt signaling at the nuclear envelope. J. Biol. Chem. 285, 34932-34938 (2010).
84. Markiewicz, E. et al. The inner nuclear membrane protein emerin regulates beta-catenin activity by restricting its accumulation in the nucleus. EMBO J. 25, 3275-3285 (2006).
85. Hernandez, L. et al. Functional coupling between the extracellular matrix and nuclear lamina by Wnt signaling in progeria. Dev. Cell 19, 413-425 (2010).
86. Shitashige, M. et al. Regulation of Wnt signaling by the nuclear pore complex. Gastroenterology 134, 1961-1971 (2008).
87. Carmo-fonseca, M. Testosterone-induced changes in nuclear pore complex number of prostatic nuclei from castrated rats. J. Ultrastruct. Res. 80, 243-251 (1982).
88. Ortiz, H. E. & Cavicchia, J. C. Androgen-induced changes in nuclear pore number and in tight junctions in rat seminal vesicle epithelium. Anat. Rec. 226, 129-134 (1990).
89. Maul, G. G. et al. Time sequence of nuclear pore formation in phytohemagglutinin-stimulated lymphocytes and in HeLa cells during the cell cycle. J. Cell Biol. 55, 433-447 (1972).
90. Maeshima, K. et al. Nuclear pore formation but not nuclear growth is governed by cyclin-dependent kinases (Cdks) during interphase. Nature Struct. Mol. Biol. 17, 1065-1071 (2010).
91. Richard, M. N., Deniset, J. F., Kneesh, A. L., Blackwood, D. & Pierce, G. N. Mechanical stretching stimulates smooth muscle cell growth, nuclear protein import, and nuclear pore expression through mitogenactivated protein kinase activation. J. Biol. Chem. 282, 23081-23088 (2007).
92. Kosako, H. et al. Phosphoproteomics reveals new ERK MAP kinase targets and links ERK to nucleoporinmediated nuclear transport. Nature Struct. Mol. Biol. 16, 1026-1035 (2009).
93. Vomastek, T. et al. Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and docking domain on the nuclear pore complex protein Tpr cooperatively regulate ERK2-Tpr interaction. Mol. Cell. Biol. 28, 6954-6966 (2008).
94. Whitehurst, A. W. et al. ERK2 enters the nucleus by a carrier-independent mechanism. Proc. Natl Acad. Sci. USA 99, 7496-7501 (2002).
95. Yazicioglu, M. N. et al. Mutations in ERK2 binding sites affect nuclear entry. J. Biol. Chem. 282, 28759-28767 (2007).
96. Smith, E. R. et al. Nuclear entry of activated MAPK is restricted in primary ovarian and mammary epithelial cells. PLoS ONE 5, e9295 (2010).
97. Huber, M. D., Guan, T. & Gerace, L. Overlapping functions of nuclear envelope proteins NET25 (Lem2) and emerin in regulation of extracellular signalregulated kinase signaling in myoblast differentiation. Mol. Cell. Biol. 29, 5718-5728 (2009).
98. Wittmann, M. et al. Synaptic activity induces dramatic changes in the geometry of the cell nucleus: interplay between nuclear structure, histone H3 phosphorylation, and nuclear calcium signaling. J. Neurosci. 29, 14687-14700 (2009).
99. Rodríguez, J. et al. ERK1/2 MAP kinases promote cell cycle entry by rapid, kinase-independent disruption of retinoblastoma-lamin A complexes. J. Cell Biol. 191, 967-979 (2010). This study reports that ERK1-ERK2 can displace RB from lamin A, independently of ERK1-ERK2 kinase activity, to promote cell cycle entry.
100. 2+ signalling. Cell Calcium 48, 215-224 (2010).
101. Parkash, J. & Asotra, K. Calcium wave signaling in cancer cells. Life Sci. 87, 587-595 (2010).
102. Gonzalez-Suarez, I. & Gonzalo, S. Nurturing the genome: A-type lamins preserve genomic stability. Nucleus 1, 129-135 (2010).
103. Manju, K., Muralikrishna, B. & Parnaik, V. K. Expression of disease-causing lamin A mutants impairs the formation of DNA repair foci. J. Cell. Sci. 119, 2704-2714 (2006).
104. Redwood, A. B. et al. A dual role for A-type lamins in DNA double-strand break repair. Cell Cycle 10, 2549-2560 (2011).
105. Johnson, B. R. et al. A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. Proc. Natl Acad. Sci. USA 101, 9677-9682 (2004).
106. Nitta, R. T., Jameson, S. A., Kudlow, B. A., Conlan, L. A. & Kennedy, B. K. Stabilization of the retinoblastoma protein by A-type nuclear lamins is required for INK4A-mediated cell cycle arrest. Mol. Cell. Biol. 26, 5360-5372 (2006).
107. Han, X. et al. Tethering by lamin A stabilizes and targets the ING1 tumour suppressor. Nat. Cell Biol. 10, 1333-1340 (2008).
108. Gonzalez-Suarez, I. et al. Novel roles for A-type lamins in telomere biology and the DNA damage response pathway. EMBO J. 28, 2414-2427 (2009).
109. Nagai, S. et al. Functional targeting of DNA damage to a nuclear pore-associated SUMO-dependent ubiquitin ligase. Science 322, 597-602 (2008).
110. Smolka, M. B., Albuquerque, C. P., Chen, S-hong & Zhou, H. Proteome-wide identification of in vivo targets of DNA damage checkpoint kinases. Proc. Natl Acad. Sci. USA 104, 10364-10369 (2007).
111. Davuluri, G. et al. Mutation of the zebrafish nucleoporin elys sensitizes tissue progenitors to replication stress. PLoS Genet. 4, e1000240 (2008).
112. Gao, N. et al. The nuclear pore complex protein Elys is required for genome stability in mouse intestinal epithelial progenitor cells. Gastroenterology 140, 1547-1555 (2011). This paper shows that removal of the mammalian nucleoporin ELYS from the developing intestinal epithelium results in activation of a DNA damage response without noticeably affecting the presence of nuclear pores.
113. Saitoh, H., Pizzi, M. D. & Wang, J. Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358. J. Biol. Chem. 277, 4755-4763 (2002).
114. Moudry, P. et al. Nucleoporin NUP153 guards genome integrity by promoting nuclear import of 53BP1. Cell Death Differ. 11 Nov. 2011 (doi:10.1038/cdd.2011. 150). This study reports the results of a screen that involved knocking down expression of more than 1, 000 genes to identify factors required for 53BP1 recruitment to ionizing radiation-induced DNA damage foci.
115. Kinoshita, Y., Kalir, T., Rahaman, J., Dottino, P. & Kohtz, D. S. Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy. Am. J. Pathol. 180, 375-389 (2012).
116. Allsopp, R. C. et al. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl Acad. Sci. USA 89, 10114-10118 (1992).
117. Huang, S., Risques, R. A., Martin, G. M., Rabinovitch, P. S. & Oshima, J. Accelerated telomere shortening and replicative senescence in human fibroblasts overexpressing mutant and wild-type lamin A. Exp. Cell Res. 314, 82-91 (2008).
118. Raz, V. et al. The nuclear lamina promotes telomere aggregation and centromere peripheral localization during senescence of human mesenchymal stem cells. J. Cell. Sci. 121, 4018-4028 (2008).
119. Dechat, T. et al. LAP2α and BAF transiently localize to telomeres and specific regions on chromatin during nuclear assembly. J. Cell. Sci. 117, 6117-6128 (2004).
120. Lisby, M., Teixeira, T., Gilson, E. & Géli, V. The fate of irreparable DNA double-strand breaks and eroded telomeres at the nuclear periphery. Nucleus 1, 158-161 (2010).
121. Ferreira, H. C. et al. The PIAS homologue Siz2 regulates perinuclear telomere position and telomerase activity in budding yeast. Nat. Cell Biol. 13, 867-874 (2011).
122. Broers, J. L. et al. Nuclear A-type lamins are differentially expressed in human lung cancer subtypes. Am. J. Pathol. 143, 211-220 (1993).
123. Moss, S. F. et al. Decreased and aberrant nuclear lamin expression in gastrointestinal tract neoplasms. Gut 45, 723-729 (1999).
124. Capo-chichi, C. D. et al. Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer. BMC Med. 9, 28 (2011).
125. Somech, R. et al. Enhanced expression of the nuclear envelope LAP2 transcriptional repressors in normal and malignant activated lymphocytes. Ann. Hematol. 86, 393-401 (2007).
126. Schneider, J. et al. Cross-reactivity between Candida albicans and human ovarian carcinoma as revealed by monoclonal antibodies PA10F and C6. Br. J. Cancer 77, 1015-1020 (1998).
127. Martínez, N., Alonso, A., Moragues, M. D., Pontón, J. & Schneider, J. The nuclear pore complex protein Nup88 is overexpressed in tumor cells. Cancer Res. 59, 5408-5411 (1999).
128. Gould, V. E. et al. Nup88 (karyoporin) in human malignant neoplasms and dysplasias: correlations of immunostaining of tissue sections, cytologic smears, and immunoblot analysis. Hum. Pathol. 33, 536-544 (2002).
129. Agudo, D. et al. Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. Int. J. Cancer 109, 717-720 (2004).
130. Knoess, M. et al. Nucleoporin 88 expression in hepatitis B and C virus-related liver diseases. World J. Gastroenterol. 12, 5870-5874 (2006).
131. Zhang, Z.-Y. et al. Nup88 expression in normal mucosa, adenoma, primary adenocarcinoma and lymph node metastasis in the colorectum. Tumour Biol. 28, 93-99 (2007).
132. Brustmann, H. & Hager, M. Nucleoporin 88 expression in normal and neoplastic squamous epithelia of the uterine cervix. Ann. Diagn. Pathol. 13, 303-307 (2009).
133. Schneider, J., Martínez-Arribas, F. & Torrejón, R. Nup88 expression is associated with myometrial invasion in endometrial carcinoma. Int. J. Gynecol. Cancer 20, 804-808 (2010).
134. Hernández, P. et al. Integrative analysis of a cancer somatic mutome. Mol. Cancer 6, 13 (2007).
135. Alfonso, P., Cañamero, M., Fernández-Carbonié, F., Núñez, A. & Casal, J. I. Proteome analysis of membrane fractions in colorectal carcinomas by using 2D-DIGE saturation labeling. J. Proteome Res. 7, 4247-4255 (2008).
136. Skvortsov, S. et al. Proteomics profiling of microdissected low-and high-grade prostate tumors identifies Lamin A as a discriminatory biomarker. J. Proteome Res. 10, 259-268 (2011).
137. Lim, S. O. et al. Proteome analysis of hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 291, 1031-1037 (2002).
138. Sun, S., Xu, M. Z., Poon, R. T., Day, P. J. & Luk, J. M. Circulating Lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients. J. Proteome Res. 9, 70-78 (2010).
139. Xie, X. et al. A comparative phosphoproteomic analysis of a human tumor metastasis model using a label-free quantitative approach. Electrophoresis 31, 1842-1852 (2010).
140. Dechat, T., Adam, S. A., Taimen, P., Shimi, T. & Goldman, R. D. Nuclear lamins. Cold Spring Harb. Perspect. Biol. 2, a000547 (2010).
141. Ballester, M. et al. Disruption of nuclear organization during the initial phase of African swine fever virus infection. J. Virol. 85, 8263-8269 (2011).
142. Foster, C. R., Przyborski, S. A., Wilson, R. G. & Hutchison, C. J. Lamins as cancer biomarkers. Biochem. Soc. Trans. 38, 297-300 (2010).
143. Wu, Z. et al. Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma. J. Exp. Clin. Cancer Res. 28, 8 (2009).
144. Agrelo, R. et al. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma. J. Clin. Oncol. 23, 3940-3947 (2005).
145. Kuramitsu, Y. et al. Proteomic analysis for nuclear proteins related to tumour malignant progression: a comparative proteomic study between malignant progressive cells and regressive cells. Anticancer Res. 30, 2093-2099 (2010).
146. Roth, U. et al. Differential expression proteomics of human colorectal cancer based on a syngeneic cellular model for the progression of adenoma to carcinoma. Proteomics 10, 194-202 (2010).
147. Wang, Y. et al. Differential protein mapping of ovarian serous adenocarcinomas: identification of potential markers for distinct tumor stage. J. Proteome Res. 8, 1452-1463 (2009).
148. Emterling, A. et al. Clinicopathological significance of Nup88 expression in patients with colorectal cancer. Oncology 64, 361-369 (2003).
149. De Keersmaecker, K. et al. Kinase activation and transformation by NUP214-ABL1 is dependent on the context of the nuclear pore. Mol. Cell 31, 134-142 (2008). The translocation and resulting fusion protein NUP214-ABL, found in ∼6% of patients with T cell acute lymphoblastic leukaemia, is shown to require localization to the NPC for its transformation activity.
150. Takeda, A., Sarma, N. J., Abdul-Nabi, A. M. & Yaseen, N. R. Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins. J. Biol. Chem. 285, 16248-16257 (2010).
151. Garçon, L. et al. DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification. Leukemia 19, 1338-1344 (2005).
152. Belt, E. J. T. et al. Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence. Eur. J. Cancer 47, 1837-1845 (2011). This study combines the analysis of A-type lamins in colon tumours with two other parameters that have been shown to have prognostic value, pointing to the potential of combining prognostic indictors for more informative stratification of patients.
153. Bussolati, G. Proper detection of the nuclear shape: ways and significance. Rom J. Morphol. Embryol. 49, 435-439 (2008).
154. Moeder, C. B., Giltnane, J. M., Moulis, S. P. & Rimm, D. L. Quantitative, fluorescence-based in-situ assessment of protein expression. Methods Mol. Biol. 520, 163-175 (2009).
155. Johannessen, J. V., Sobrinho-Simões, M., Finseth, I. & Pilström, L. Papillary carcinomas of the thyroid have pore-deficient nuclei. Int. J. Cancer 30, 409-411 (1982).
156. Czerniak, B., Koss, L. G. & Sherman, A. Nuclear pores and DNA ploidy in human bladder carcinomas. Cancer Res. 44, 3752-3756 (1984).
157. Sugie, S., Yoshimi, N., Tanaka, T., Mori, H. & Williams, G. M. Alterations of nuclear pores in preneoplastic and neoplastic rat liver lesions induced by 2-acetylaminofluorene. Carcinogenesis 15, 95-98 (1994).
158. Lewin, J. M., Lwaleed, B. A., Cooper, A. J. & Birch, B. R. The direct effect of nuclear pores on nuclear chemotherapeutic concentration in multidrug resistant bladder cancer: the nuclear sparing phenomenon. J. Urol. 177, 1526-1530 (2007).
159. Webster, M., Witkin, K. L. & Cohen-Fix, O. Sizing up the nucleus: nuclear shape, size and nuclearenvelope assembly. J. Cell. Sci. 122, 1477-1486 (2009).
160. Lee, A. S. & Hendershot, L. M. ER stress and cancer. Cancer Biol. Ther. 5, 721-722 (2006).
161. Politi, K. & Pao, W. How genetically engineered mouse tumor models provide insights into human cancers. J. Clin. Oncol. 29, 2273-2281 (2011).
162. Goldberg, M. W., Huttenlauch, I., Hutchison, C. J. & Stick, R. Filaments made from A-and B-type lamins differ in structure and organization. J. Cell. Sci. 121, 215-225 (2008).
163. Sullivan, T. et al. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J. Cell Biol. 147, 913-920 (1999).
164. Ralle, T., Grund, C., Franke, W. W. & Stick, R. Intranuclear membrane structure formations by CaaX-containing nuclear proteins. J. Cell. Sci. 117, 6095-6104 (2004).
165. Polychronidou, M., Hellwig, A. & Grosshans, J. Farnesylated nuclear proteins Kugelkern and lamin Dm0 affect nuclear morphology by directly interacting with the nuclear membrane. Mol. Biol. Cell 21, 3409-3420 (2010).
166. Simon, D. N., Zastrow, M. S. & Wilson, K. L. Direct actin binding to A-and B-type lamin tails and actin filament bundling by the lamin A tail. Nucleus 1, 264-272 (2010).
167. Holaska, J. M., Kowalski, A. K. & Wilson, K. L. Emerin caps the pointed end of actin filaments: evidence for an actin cortical network at the nuclear inner membrane. PLoS Biol. 2, E231 (2004).
168. Antonin, W., Ungricht, R. & Kutay, U. Traversing the NPC along the pore membrane: targeting of membrane proteins to the INM. Nucleus 2, 87-91 (2011).
169. Liu, Q. et al. Functional association of Sun1 with nuclear pore complexes. J. Cell Biol. 178, 785-798 (2007).
170. Hawryluk-Gara, L. A., Shibuya, E. K. & Wozniak, R. W. Vertebrate Nup53 interacts with the nuclear lamina and is required for the assembly of a Nup93-containing complex. Mol. Biol. Cell 16, 2382-2394 (2005).
171. Lussi, Y. C., Hügi, I., Laurell, E., Kutay, U. & Fahrenkrog, B. The nucleoporin Nup88 is interacting with nuclear lamin A. Mol. Biol. Cell 22, 1080-1090 (2011).
172. Smythe, C., Jenkins, H. E. & Hutchison, C. J. Incorporation of the nuclear pore basket protein nup153 into nuclear pore structures is dependent upon lamina assembly: evidence from cell-free extracts of Xenopus eggs. EMBO J. 19, 3918-3931 (2000).
173. Mackay, D. R., Elgort, S. W. & Ullman, K. S. The nucleoporin Nup153 has separable roles in both early mitotic progression and the resolution of mitosis. Mol. Biol. Cell 20, 1652-1660 (2009).
174. D'Angelo, M. A., Raices, M., Panowski, S. H. & Hetzer, M. W. Age-dependent deterioration of nuclear pore complexes causes a loss of nuclear integrity in postmitotic cells. Cell 136, 284-295 (2009).
175. Scaffidi, P. & Misteli, T. Lamin A-dependent nuclear defects in human aging. Science 312, 1059-1063 (2006).
176. Tang, Y., Chen, Y., Jiang, H. & Nie, D. Promotion of tumor development in prostate cancer by progerin. Cancer Cell. Int. 10, 47 (2010).
177. Espada, J. et al. Nuclear envelope defects cause stem cell dysfunction in premature-aging mice. J. Cell Biol. 181, 27-35 (2008).
178. Mason, M. J., Fan, G., Plath, K., Zhou, Q. & Horvath, S. Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells. BMC Genomics 10, 327 (2009).
179. Lupu, F., Alves, A., Anderson, K., Doye, V. & Lacy, E. Nuclear pore composition regulates neural stem/progenitor cell differentiation in the mouse embryo. Dev. Cell 14, 831-842 (2008).
180. Scaffidi, P. & Misteli, T. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat. Cell Biol. 10, 452-459 (2008).
181. Doucet, C. M. & Hetzer, M. W. Nuclear pore biogenesis into an intact nuclear envelope. Chromosoma 119, 469-477 (2010).
182. Malhas, A., Goulbourne, C. & Vaux, D. J. The nucleoplasmic reticulum: form and function. Trends Cell Biol. 21, 362-373 (2011).
183. Venables, R. S. et al. Expression of individual lamins in basal cell carcinomas of the skin. Br. J. Cancer 84, 512-519 (2001).
184. Tilli, C. M. L. J., Ramaekers, F. C. S., Broers, J. L. V., Hutchison, C. J. & Neumann, H. A. M. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma. B r. J. Dermatol. 148, 102-109 (2003).
185. Bengtsson, S. et al. Large-scale proteomics analysis of human ovarian cancer for biomarkers. J. Proteome Res. 6, 1440-1450 (2007).
186. Coradeghini, R. et al. Differential expression of nuclear lamins in normal and cancerous prostate tissues. Oncol. Rep. 15, 609-613 (2006).
187. Doherty, J. A. et al. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an ovarian cancer association consortium study. Cancer Epidemiol. Biomarkers Prev. 19, 245-250 (2010).
188. Sjöblom, T. et al. The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274 (2006).
189. Zhao, Z.-R. et al. Increased serum level of Nup88 protein is associated with the development of colorectal cancer. Med. Oncol. 24 Aug. 2011 (doi:10.1007/s12032-011-0047-1).